BR0315917A - Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais - Google Patents

Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais

Info

Publication number
BR0315917A
BR0315917A BR0315917-5A BR0315917A BR0315917A BR 0315917 A BR0315917 A BR 0315917A BR 0315917 A BR0315917 A BR 0315917A BR 0315917 A BR0315917 A BR 0315917A
Authority
BR
Brazil
Prior art keywords
carboxymethyl
cyano
salt
dystronic
gastroduodenal
Prior art date
Application number
BR0315917-5A
Other languages
English (en)
Inventor
Yannis Tsuoderos
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0315917A publication Critical patent/BR0315917A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"UTILIZAçãO DO SAL DISTRÈNICO DO áCIDO 2¢N,N-DI(CARBOXIMETIL)AMINO!-3-CIANO-4-CARBOXIMETIL-TI OFENO5-CARBOXìLICO PARA A OBTENçãO DE MEDICAMENTOS DESTINADOS AO TRATAMENTO DAS DORES GASTRODUODENAIS". A presente invenção refere-se à utilização do sal distrónico do ácido 2-¢N,N-di(carboximetil)aminol-3-ciano-4-carboximetil-tiofeno-5-carbox ílico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais
BR0315917-5A 2002-11-05 2003-11-04 Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais BR0315917A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213805A FR2846558B1 (fr) 2002-11-05 2002-11-05 Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
PCT/FR2003/003279 WO2004043455A1 (fr) 2002-11-05 2003-11-04 Utilisation du sel distrontique de l'acide 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales

Publications (1)

Publication Number Publication Date
BR0315917A true BR0315917A (pt) 2005-09-20

Family

ID=32104443

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315917-5A BR0315917A (pt) 2002-11-05 2003-11-04 Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais

Country Status (25)

Country Link
US (1) US7544710B2 (pt)
EP (1) EP1560578B1 (pt)
JP (1) JP4335146B2 (pt)
KR (1) KR100735348B1 (pt)
CN (1) CN1705479B (pt)
AT (1) ATE328591T1 (pt)
AU (1) AU2003292325B2 (pt)
BR (1) BR0315917A (pt)
CA (1) CA2503975C (pt)
CY (1) CY1105105T1 (pt)
DE (1) DE60305962T2 (pt)
DK (1) DK1560578T3 (pt)
EA (1) EA007863B1 (pt)
ES (1) ES2264010T3 (pt)
FR (1) FR2846558B1 (pt)
GE (1) GEP20084463B (pt)
MA (1) MA27406A1 (pt)
MX (1) MXPA05004792A (pt)
NO (1) NO333599B1 (pt)
NZ (1) NZ539516A (pt)
PL (1) PL214704B1 (pt)
PT (1) PT1560578E (pt)
UA (1) UA78618C2 (pt)
WO (1) WO2004043455A1 (pt)
ZA (1) ZA200503082B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
WO2005123098A2 (en) * 2004-06-17 2005-12-29 Osteologix A/S Preventing gastrointestinal side-effects with strontium salts
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US6489356B2 (en) * 2000-09-05 2002-12-03 Edward Leung Method for treating pain in humans

Also Published As

Publication number Publication date
MXPA05004792A (es) 2005-07-22
DE60305962D1 (de) 2006-07-20
WO2004043455A1 (fr) 2004-05-27
MA27406A1 (fr) 2005-06-01
FR2846558A1 (fr) 2004-05-07
PL375960A1 (en) 2005-12-12
CN1705479B (zh) 2010-04-28
JP2006508112A (ja) 2006-03-09
HK1084029A1 (en) 2006-07-21
US7544710B2 (en) 2009-06-09
DE60305962T2 (de) 2007-02-08
NO20052562L (no) 2005-05-26
ZA200503082B (en) 2006-07-26
CA2503975A1 (fr) 2004-05-27
CA2503975C (fr) 2010-05-25
CY1105105T1 (el) 2009-11-04
AU2003292325A1 (en) 2004-06-03
US20060014824A1 (en) 2006-01-19
EP1560578A1 (fr) 2005-08-10
EA007863B1 (ru) 2007-02-27
KR100735348B1 (ko) 2007-07-04
NZ539516A (en) 2007-11-30
PL214704B1 (pl) 2013-09-30
JP4335146B2 (ja) 2009-09-30
AU2003292325B2 (en) 2008-07-31
KR20050072476A (ko) 2005-07-11
EP1560578B1 (fr) 2006-06-07
UA78618C2 (uk) 2007-04-10
ATE328591T1 (de) 2006-06-15
CN1705479A (zh) 2005-12-07
PT1560578E (pt) 2006-09-29
EA200500687A1 (ru) 2005-10-27
FR2846558B1 (fr) 2006-07-14
DK1560578T3 (da) 2006-10-02
NO333599B1 (no) 2013-07-22
ES2264010T3 (es) 2006-12-16
GEP20084463B (en) 2008-08-25

Similar Documents

Publication Publication Date Title
BR0213358A (pt) Uso de flibanserina
MX2012004625A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
TR200001795T2 (tr) 1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı.
BRPI0409109A (pt) novos compostos
BG106251A (en) Levodopa (carbidopa) entacapone pharmaceutical preparation
ES2330291A1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EP1576986A3 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
NZ591873A (en) Co-crystals of tramadol and nsaids
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
FR2848428B1 (fr) Composition cosmetique et procede pour le traitement des matieres keratiniques, comprenant un compose photodimerisable
GB2431346B (en) A combination composition comprising paracetamol and ibuprofen
DK1643999T3 (da) Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
BR0315917A (pt) Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais
UA81573C2 (en) Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients
BR9913337A (pt) Derivados tan-1057
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
EE04176B1 (et) Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2435 DE 05-09-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.